News
With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...
(Reuters) -AbbVie said on Wednesday its migraine drug met the main goal and was superior to a widely used generic treatment ...
Zoetis was created in 2013 after splitting off from Pfizer’s animal health division. While it may not seem like a household ...
The convergence of stringent global regulations, rising counterfeit risks, and digital supply chain transformation is creating strong momentum for the Track and Trace Solutions Market. While ...
Early June 17, the Israeli army allegedly killed at least 51 Palestinians waiting for aid in Khan Younis, in the southern ...
To rein in rising costs, employers can contract directly with a PBM, as well as avoid schemes involving rebates and ...
Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer FDA recommends inclusion of patients as young as 6 months - younger than ...
Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...
Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the debut of a powerful new ...
FDA recommends inclusion of patients as young as 6 months - younger than Moleculin had proposed - to be allowed in the ...
"The POSITANO study shows that CAM2029 significantly reduces liver and liver cyst volume compared to placebo while showing improvements in symptoms as assessed by relevant patient ...
Introduction Over the past few years, the European Union has been actively working to overhaul its pharmaceutical legislative framework to better address unmet medical needs, such as those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results